Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins

Experimental Dermatology

Volumn 23, Issue 4, 2014, Pages 253-259

  Langenhan, Jana ^a   Dworschak, Jenny ^b   Saschenbrecker, Sandra ^a   Komorowski, Lars ^a   Schlumberger, Wolfgang ^a   Stöcker, Winfried ^a   Westermann, Jürgen ^b   Recke, Andreas ^b   Zillikens, Detlef ^b   Schmidt, Enno ^b   Probst, Christian ^a  

^a Institute of Experimental Immunology   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Autoantibodies; Immunoadsorption; Pemphigus

Indexed keywords

AUTOANTIBODY; DESMOGLEIN; DESMOGLEIN 1; DESMOGLEIN 3; EPITOPE; IMMUNOGLOBULIN G; SEPHAROSE; DSG1 PROTEIN, HUMAN; DSG3 PROTEIN, HUMAN;

ACANTHOLYSIS; ADSORPTION; ARTICLE; CELL STRAIN HEK293; CONFORMATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EPITOPE MAPPING; HUMAN; IMMUNOADSORPTION; IMMUNOFLUORESCENCE; KERATINOCYTE DISSOCIATION ASSAY; MUCOSA; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PEMPHIGUS; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEK293 CELL LINE; IMMUNOLOGY; PROTEIN TERTIARY STRUCTURE;

CASE-CONTROL STUDIES; DESMOGLEIN 1; DESMOGLEIN 3; EPITOPE MAPPING; HEK293 CELLS; HUMANS; IMMUNOSORBENT TECHNIQUES; PEMPHIGUS; PROTEIN STRUCTURE, TERTIARY;

EID: 84896930878     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12355     Document Type: Article

References (42)

1. Stanley J R, Amagai M. N Engl J Med 2006: 355: 1800-1810.
2. Schmidt E, Zillikens D. Dtsch Ärztebl Int 2011: 108: 399-405.
3. Eyre R W, Stanley J R. J Clin Invest 1988: 81: 807-812.
4. Hashimoto T, Ogawa M M, Konohana A et al. J Invest Dermatol 1990: 94: 327-331.
5. Koch P J, Walsh M J, Schmelz M et al. Eur J Cell Biol 1990: 53: 1-12.
6. Amagai M, Klaus-Kovtun V, Stanley J R. Cell 1991: 67: 869-877.
7. Ding X, Aoki V, Mascaro J M Jr et al. J Invest Dermatol 1997: 109: 592-596.
8. Rafei D, Muller R, Ishii N et al. Am J Pathol 2011: 178: 718-723.
9. Kalantari-Dehaghi M, Molina D M, Farhadieh M et al. Exp Dermatol 2011: 20: 154-156.
10. Ujiie H, Shimizu H. Exp Dermatol 2012: 21: 901-905.
11. Ishii K, Harada R, Matsuo I et al. J Invest Dermatol 2005: 124: 939-946.
12. Schiltz J R, Michel B. J Invest Dermatol 1976: 67: 254-260.
13. Anhalt G J, Labib R S, Voorhees J J et al. N Engl J Med 1982: 306: 1189-1196.
14. Ishii K, Amagai M, Hall R P et al. J Immunol 1997: 159: 2010-2017.
15. Harman K E, Seed P T, Gratian M J et al. Br J Dermatol 2001: 144: 775-780.
16. Schmidt E, Dähnrich C, Rosemann A et al. Exp Dermatol 2010: 19: 458-463.
17. Mahoney M G, Wang Z, Rothenberger K et al. J Clin Invest 1999: 103: 461-468.
18. Amagai M, Hashimoto T, Shimizu N et al. J Clin Invest 1994: 94: 59-67.
19. Amagai M, Hashimoto T, Green K J et al. J Invest Dermatol 1995: 104: 895-901.
20. Payne A S, Ishii K, Kacir S et al. J Clin Invest 2005: 115: 888-899.
21. Ishii K, Lin C, Siegel D L et al. J Invest Dermatol 2008: 128: 939-948.
22. Di Zenzo G, Di Lullo G, Corti D et al. J Clin Invest 2012: 122: 3781-3790.
23. Amagai M, Karpati S, Prussick R et al. J Clin Invest 1992: 90: 919-926.
24. Li N, Aoki V, Hans-Filho G et al. J Exp Med 2003: 197: 1501-1510.
25. Yokouchi M, Saleh M A, Kuroda K et al. J Invest Dermatol 2009: 129: 2156-2166.
26. Dworschak J, Recke A, Freitag M et al. J Dermatol Sci 2011: 65: 102-109.
27. Yamagami J, Payne A S, Kacir S et al. J Clin Invest 2010: 120: 4111-4117.
28. Bystryn J C, Rudolph J L. Lancet 2005: 366: 61-73.
29. Waschke J. Histochem Cell Biol 2008: 130: 21-54.
30. Lüftl M, Stauber A, Mainka A et al. Br J Dermatol 2003: 149: 598-605.
31. Schmidt E, Klinker E, Opitz A et al. Br J Dermatol 2003: 148: 1222-1229.
32. Aoyama Y, Nagasawa C, Nagai M et al. Eur J Dermatol 2008: 18: 557-560.
33. Schmidt E, Zillikens D. Arch Dermatol Res 2010: 302: 241-253.
34. Murrell D F, Dick S, Ahmed A R et al. J Am Acad Dermatol 2008: 58: 1043-1046.
35. Bhol K, Natarajan K, Nagarwalla N et al. Proc Natl Acad Sci USA 1995: 92: 5239-5243.
36. Futei Y, Amagai M, Sekiguchi M et al. J Invest Dermatol 2000: 115: 829-834.
37. Sekiguchi M, Futei Y, Fujii Y et al. J Immunol 2001: 167: 5439-5448.
38. Amagai M, Ishii K, Hashimoto T et al. J Invest Dermatol 1995: 105: 243-247.
39. Chan P T, Ohyama B, Nishifuji K et al. Br J Dermatol 2010: 162: 1242-1250.
40. Ohyama B, Nishifuji K, Chan P T et al. J Invest Dermatol 2012: 132: 1158-1168.
41. Müller R, Svoboda V, Wenzel E et al. Exp Dermatol 2008: 17: 35-43.
42. Chappuis-Flament S, Wong E, Hicks L D et al. J Cell Biol 2001: 154: 231-243.